Search research articles
Contact Us
Filters
Showing results (201-210 of 286) with videos related to
Page
of 29
Sort By:
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
GFAP Degradation in TBI: Linking Novel Modified Products to Astrocyte Pathology and Patient Outcome
Ina-Beate Wanner, Julia Halford, Jonathan Lopez, et al.
Scientific Reports
|
July 23, 2021
Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging
Hamed Akbari, Anahita Fathi Kazerooni, Jeffrey B Ware, et al.
Neuro-Oncology
|
December 18, 2019
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
Timothy F Cloughesy, Andrew Brenner, John F de Groot, et al.
Neuro-Oncology Advances
|
May 12, 2026
A single-institution retrospective study of multicentric gliomas stratified by <i>IDH</i> mutational status
Chuyin Yang, Ryan Mostafavi, Collin Le, et al.
Neuro-Oncology
|
August 31, 2016
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy
HuyTram N Nguyen, Amy Lie, Tie Li, et al.
Neuro-Oncology
|
May 9, 2019
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI
Jingwen Yao, Ararat Chakhoyan, David A Nathanson, et al.
Neuro-Oncology Advances
|
March 7, 2025
A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma
Benjamin M Ellingson, Qunicy Okobi, Robert Chong, et al.
Neuro-Oncology
|
October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio
Martha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
Neuro-Oncology
|
September 1, 2025
Perfusion, diffusion, and anatomical MRI characteristics of pathologically-confirmed malignant transformation in IDH-mutant gliomas
Nicholas S Cho, Viên Lam Le, Ashley Teraishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab
Raymond Y Huang, Rifaquat Rahman, Karla V Ballman, et al.
Page
of 29
Search research articles
Search
Showing results (201-210 of 286) with videos related to
Sort By:
Page
of 29
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
GFAP Degradation in TBI: Linking Novel Modified Products to Astrocyte Pathology and Patient Outcome
Ina-Beate Wanner, Julia Halford, Jonathan Lopez, et al.
Scientific Reports
|
July 23, 2021
Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging
Hamed Akbari, Anahita Fathi Kazerooni, Jeffrey B Ware, et al.
Neuro-Oncology
|
December 18, 2019
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
Timothy F Cloughesy, Andrew Brenner, John F de Groot, et al.
Neuro-Oncology Advances
|
May 12, 2026
A single-institution retrospective study of multicentric gliomas stratified by <i>IDH</i> mutational status
Chuyin Yang, Ryan Mostafavi, Collin Le, et al.
Neuro-Oncology
|
August 31, 2016
Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy
HuyTram N Nguyen, Amy Lie, Tie Li, et al.
Neuro-Oncology
|
May 9, 2019
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI
Jingwen Yao, Ararat Chakhoyan, David A Nathanson, et al.
Neuro-Oncology Advances
|
March 7, 2025
A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma
Benjamin M Ellingson, Qunicy Okobi, Robert Chong, et al.
Neuro-Oncology
|
October 11, 2017
Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio
Martha Nowosielski, Benjamin M Ellingson, Olivier L Chinot, et al.
Neuro-Oncology
|
September 1, 2025
Perfusion, diffusion, and anatomical MRI characteristics of pathologically-confirmed malignant transformation in IDH-mutant gliomas
Nicholas S Cho, Viên Lam Le, Ashley Teraishi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 23, 2015
The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab
Raymond Y Huang, Rifaquat Rahman, Karla V Ballman, et al.
Page
of 29